赛托生物(300583.SZ)发布前三季度业绩，归母净亏损6923.03万元

Core Insights - The company reported a revenue of 749 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 2.07% [1] - The net loss attributable to shareholders of the listed company was 69.23 million yuan [1] - The net loss attributable to shareholders, excluding non-recurring gains and losses, was 72.39 million yuan [1] - The basic loss per share was 0.36 yuan [1]